Differential Expression and Distribution of Slco4a1 and Slco1b2 in an Internal Environment Disorder-induced
Haoxuan Luo1, Yang Xie2, Shan Huang1
1School of Traditional Chinese Medicine, Chongqing Medical and Pharmaceutical College, Chongqing, 401331, China.
Objective:
This study aims to enhance the understanding of underlying mechanisms and potential therapies of the solute carrier organic anion (SLCO) transporter family in internal environment disorder (IED)-induced hepatocellular carcinoma (HCC). This could lead to new therapeutic strategies and offer new directions for the creation of new patents for HCC treatment products.
Methods:
The orthotopic transplantation (OT), IED and IED-based OT (IED-OT) mouse models were established. Expression patterns of Slco4a1 and Slco1b2 were determined using reverse transcription quantitative polymerase chain reaction (RT-qPCR), western blotting (WB) and immunohistochemistry (IHC) in various tissues, including lung, stomach, liver, spleen, kidney, colon, small intestine, HCC tissues and adjacent non-cancerous tissues.
Results:
Animals exhibited symptoms, including weight loss, lethargy, chills, dyspnea, altered hair texture, and gastrointestinal disturbances, confirming the successful establishment of the IED model. The analysis demonstrated differential expression and tissue-specific distribution of Slco4a1 and Slco1b2, which are associated with IED-induced changes. These alterations potentially disrupt organ transport functions, thereby promoting the development of HCC. Additionally, they suggest a role in rebalancing the tumor microenvironment and mitigating damage resulting from abnormal substance accumulation.
Discussion:
This study reveals that IED promotes HCC progression by altering the expression and distribution of Slco4a1 and Slco1b2, leading to transport dysfunction in affected organs. Furthermore, IED and OT exhibit synergistic effects in HCC development. These findings enhance the understanding of the underlying mechanisms of IED related HCC. Future studies should establish animal models incorporating both internal and external factors, with cellular experiments needed to further validate the mechanisms.
Conclusion:
Changes in SLCO expression and distribution induced by IED may play pivotal roles in the development of HCC. These findings contribute insights that could inform novel therapeutic strategies against HCC.
Insights
Altered expression of solute carrier organic anion (SLCO) transporters is linked to internal environment disorder (IED)-induced liver cancer (HCC). These changes may drive HCC development and offer new therapeutic targets.
Area of Science:
- Hepatobiliary diseases
- Molecular biology
- Oncology
Background:
- Internal environment disorder (IED) is increasingly implicated in the pathogenesis of various diseases.
- The solute carrier organic anion (SLCO) transporter family plays crucial roles in the transport of endogenous and exogenous compounds.
- Understanding the role of SLCOs in IED-induced hepatocellular carcinoma (HCC) is essential for developing targeted therapies.
Purpose of the Study:
- To investigate the expression patterns and functional significance of SLCO transporters in the context of IED-induced HCC.
- To elucidate the mechanisms by which SLCO alterations contribute to HCC development.
- To identify potential therapeutic targets for HCC treatment.
Main Methods:
- Establishment of orthotopic transplantation (OT), IED, and IED-based OT (IED-OT) mouse models.
- Quantitative analysis of Slco4a1 and Slco1b2 expression using RT-qPCR, western blotting, and immunohistochemistry in various tissues.
- Assessment of IED-induced physiological changes in animal models.
Main Results:
- Successful establishment of IED and IED-OT mouse models, confirmed by characteristic symptoms.
- Differential expression and tissue-specific distribution of Slco4a1 and Slco1b2 were observed in IED-affected tissues, including HCC.
- These SLCO alterations are associated with disrupted organ transport functions and may promote HCC development by affecting the tumor microenvironment.
Conclusions:
- Changes in SLCO transporter expression and distribution induced by IED are critical factors in HCC development.
- These findings provide valuable insights into the molecular mechanisms underlying IED-associated HCC.
- The study highlights SLCOs as potential targets for novel HCC therapeutic strategies.
